The Federal Aviation Administration proposed a rule change on August 4, 2025, that would give commercial airlines greater flexibility in stocking emergency medical kits. According to a report by David Shepardson for Reuters, the agency wants to shift away from a rigid, prescriptive checklist of medical items in favor of performance-based standards.
New Performance Standards for Nine Medical Emergencies
Under the proposed framework detailed by Reuters, carriers would no longer have to follow a strict inventory of 64 distinct items. Instead, airlines must ensure their kits contain sufficient resources to manage nine specific life-threatening conditions identified by regulators. Those conditions include cardiac emergencies, breathing difficulties, gastrointestinal emergencies, opioid overdoses, childbirth, seizures, severe allergic reactions, major bleeding, and hypoglycemia. While airlines would gain the autonomy to determine exact items and quantities, aircraft would still be legally required to carry external defibrillators, according to the Reuters report.
In-Flight Medical Incident Data and Diversions
The regulatory shift follows a 2025 Duke Health study review of 77,000 in-flight medical events spanning January 2022 to December 2023. According to data cited by Reuters from 84 airlines across six continents representing over 3.1 billion passenger boardings, one in every 212 flights involves a medical emergency. While the majority of incidents are minor, the data shows that about 8% of affected passengers require hospital care after landing, and roughly 1.7% of events are severe enough to trigger unscheduled aircraft diversions.
Supply Chain Challenges and Regulatory Exemptions
Airlines frequently face medication shortages that complicate efforts to maintain fully compliant emergency kits, an issue the new rule aims to address. Because an incomplete kit technically prevents an airline from operating a flight, carriers must currently petition the FAA for exemptions. Reuters noted a historical precedent from 2013, when the agency granted an exemption due to a shortage of dextrose, a critical medication used to treat severe, life-threatening hypoglycemia. The proposed performance-based standards would allow airlines to secure alternative replacements for items like dextrose without being forced to seek formal regulatory exemptions.
Related reading